Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia
… [11] reported that the outpatient PPI … systematic review of 11 observational and meta-analysis
of 7 observational studies, we identified high association between PPI therapy and the risk …
of 7 observational studies, we identified high association between PPI therapy and the risk …
Proton pump inhibitors and community acquired pneumonia
KB Filion - BMJ, 2016 - bmj.com
… about proton pump inhibitors (PPIs) and the risk of community acquired pneumonia initially
… ,1 in which the risk of community acquired pneumonia was significantly higher among current …
… ,1 in which the risk of community acquired pneumonia was significantly higher among current …
Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study
… Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a
systematic review and meta-analysis. PLoS One 2015;10:e0128004. doi:10.1371/journal.pone.…
systematic review and meta-analysis. PLoS One 2015;10:e0128004. doi:10.1371/journal.pone.…
Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta‐analysis of randomized controlled trials and observational studies
… the current evidence regarding the risk of pneumonia associated with proton pump
inhibitors (PPI) treatment. … of community-acquired pneumonia (CAP) but also hospital-acquired …
inhibitors (PPI) treatment. … of community-acquired pneumonia (CAP) but also hospital-acquired …
[HTML][HTML] Proton-pump inhibitor use and risk of community-acquired pneumonia in congenital heart disease patients
… Adults with congenital heart disease (CHD) are at elevated risk of hospitalization for
community-acquired pneumonia (CAP). Proton-pump inhibitors (PPIs) have been shown to be a risk …
community-acquired pneumonia (CAP). Proton-pump inhibitors (PPIs) have been shown to be a risk …
The risk of community-acquired enteric infection in proton pump inhibitor therapy: systematic review and meta-analysis
… In conclusion, this updated review confirms the risk of developing community-acquired
enteric infection associated with PPI use and demonstrates that the association is stronger for …
enteric infection associated with PPI use and demonstrates that the association is stronger for …
Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence
ML Maes, DR Fixen… - Therapeutic advances in …, 2017 - journals.sagepub.com
… , including increased risk of community-acquired pneumonia (… , immunosuppressants, or
systemic corticosteroids in the … ; and any hospitalization or outpatient claim for inflammatory …
systemic corticosteroids in the … ; and any hospitalization or outpatient claim for inflammatory …
[HTML][HTML] Use of proton pump inhibitors is associated with a higher risk of pneumonia in cirrhotic patients: a systematic review and meta-analysis
W Wongtrakul, N Charoenngnam… - Annals of …, 2020 - ncbi.nlm.nih.gov
… In fact, a study by Viasus et al identified an increased proportion of Streptococcus pneumoniae
as a causative organism of community-acquired pneumonia in patients with cirrhosis …
as a causative organism of community-acquired pneumonia in patients with cirrhosis …
Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies
J Almirall, M Serra-Prat, I Bolíbar, V Balasso - Respiration, 2017 - karger.com
… was to assess risk factors for CAP in both hospitalized and ambulatory adult patients with …
therapy, oral steroids, and treatment with proton pump inhibitors or H 2 antagonists as …
therapy, oral steroids, and treatment with proton pump inhibitors or H 2 antagonists as …
Drugs that increase the risk of community-acquired pneumonia: a narrative review
A Liapikou, C Cilloniz, A Torres - Expert opinion on drug safety, 2018 - Taylor & Francis
… and systematic reviews have identified a large number of risk … corticosteroids (ICSs), the
proton pump inhibitors (PPIs), the … a pooled risk for CAP with ambulatory PPI therapy of 1.49 (95…
proton pump inhibitors (PPIs), the … a pooled risk for CAP with ambulatory PPI therapy of 1.49 (95…